The French government cancelled a decree that allowed French hospital doctors to administer hydroxychloroquine treatment to patients suffering from Covid-19.
The announcement comes right after two days when the World Health Organization paused a large trial of the malaria drug because of the safety concerns.
The Lancet, British medical journal, reported that patients who are treated with hydroxychloroquine had increased irregular heartbeats and death rates, adding a series of other disappointing results for the drug to treat Covid-19.
Reminding you that the US President Donald Trump and others have pushed hydroxychloroquine in recent months as coronavirus treatment.
“I think it’s good. I’ve heard a lot of good stories,” Trump said, declaring hydroxychloroquine safe.
But later on, Trump dismissed the opinions once after his experts warned of the serious risks associated with the hydroxychloroquine treatment, highlighting poisonings and heart problems reported by the Food and Drug Administration.
France also decided at the end of March to use hydroxychloroquine in hospitals only, and only in specific situations.
But recently, chief Tedros Adhanom Ghebreyesus of WHO said “implemented a temporary pause … while the safety data is reviewed”, referring to the hydroxychloroquine arm of a global trial as a possible treatment.